These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21651616)

  • 1. Possible drug-drug interaction between quetiapine and lamotrigine--evidence from a Swedish TDM database.
    Andersson ML; Björkhem-Bergman L; Lindh JD
    Br J Clin Pharmacol; 2011 Jul; 72(1):153-6. PubMed ID: 21651616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets.
    Hole K; Lorentsen SK; Nordby KL; Slettvik M; Sørum IT; Molden E; Haslemo T
    Eur J Clin Pharmacol; 2024 Jun; 80(6):839-845. PubMed ID: 38396309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine and drug interactions: evidence from a routine therapeutic drug monitoring service.
    Castberg I; Skogvoll E; Spigset O
    J Clin Psychiatry; 2007 Oct; 68(10):1540-5. PubMed ID: 17960969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine is a substrate for OCT1 in brain endothelial cells.
    Dickens D; Owen A; Alfirevic A; Giannoudis A; Davies A; Weksler B; Romero IA; Couraud PO; Pirmohamed M
    Biochem Pharmacol; 2012 Mar; 83(6):805-14. PubMed ID: 22227272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patients.
    Bakken GV; Rudberg I; Molden E; Refsum H; Hermann M
    Ther Drug Monit; 2011 Apr; 33(2):222-6. PubMed ID: 21383647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine drug interactions in a TDM material.
    Böttiger Y; Svensson JO; Ståhle L
    Ther Drug Monit; 1999 Apr; 21(2):171-4. PubMed ID: 10217336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between daily dose, plasma concentrations, dopamine receptor occupancy, and clinical response to quetiapine: a review.
    Sparshatt A; Taylor D; Patel MX; Kapur S
    J Clin Psychiatry; 2011 Aug; 72(8):1108-23. PubMed ID: 21294996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual clearance and therapeutic drug monitoring of quetiapine in clinical practice.
    Wittmann M; Hausner H; Köstlbacher A; Hajak G; Haen E
    Neuro Endocrinol Lett; 2010; 31(2):203-7. PubMed ID: 20424588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations.
    Aichhorn W; Marksteiner J; Walch T; Zernig G; Saria A; Kemmler G
    Int Clin Psychopharmacol; 2006 Mar; 21(2):81-5. PubMed ID: 16421458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.
    DeVane CL; Nemeroff CB
    Clin Pharmacokinet; 2001; 40(7):509-22. PubMed ID: 11510628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring.
    Vella T; Mifsud J
    J Pharm Pharmacol; 2014 Jun; 66(6):747-59. PubMed ID: 24392714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine.
    Wong YW; Yeh C; Thyrum PT
    J Clin Psychopharmacol; 2001 Feb; 21(1):89-93. PubMed ID: 11199955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone and lamotrigine: no evidence of a drug interaction.
    Castberg I; Spigset O
    J Clin Psychiatry; 2006 Jul; 67(7):1159. PubMed ID: 16889467
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers.
    Jann MW; Hon YY; Shamsi SA; Zheng J; Awad EA; Spratlin V
    Pharmacotherapy; 2006 May; 26(5):627-33. PubMed ID: 16637792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antiepileptic drug comedication on lamotrigine concentrations.
    Lovrić M; Čajić I; Petelin Gadže Ž; Klarica Domjanović I; Božina N
    Croat Med J; 2018 Feb; 59(1):13-19. PubMed ID: 29498493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders.
    Winter HR; Earley WR; Hamer-Maansson JE; Davis PC; Smith MA
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):81-98. PubMed ID: 18294091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects.
    Gastrup S; Stage TB; Fruekilde PB; Damkier P
    Br J Clin Pharmacol; 2016 Apr; 81(4):735-41. PubMed ID: 26588196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions.
    Reimers A; Skogvoll E; Sund JK; Spigset O
    Eur J Clin Pharmacol; 2007 Jul; 63(7):687-92. PubMed ID: 17497143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
    Henderson DC; Copeland PM; Borba CP; Daley TB; Nguyen DD; Cagliero E; Evins AE; Zhang H; Hayden DL; Freudenreich O; Cather C; Schoenfeld DA; Goff DC
    J Clin Psychiatry; 2006 May; 67(5):789-97. PubMed ID: 16841629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole.
    Härtter S; Connemann B; Schönfeldt-Lecuona C; Sachse J; Hiemke C
    J Clin Psychopharmacol; 2004 Oct; 24(5):568-71. PubMed ID: 15349025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.